Active Vaccine Safety Surveillance (AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives

Active Vaccine Safety Surveillance (AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives

Active Vaccine Safety Surveillance
(AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives

Active Vaccine Safety Surveillance
(AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives

Active Vaccine Safety Surveillance
(AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives

Active Vaccine Safety Surveillance
(AVSS) Platform


Comprehensive platform for supporting countries
in their vaccination safety and surveillance initiatives
ABOUT ACTIVE VACCINE SURVIELLANCE (AVSS) PLATFORM

Registration and risk assessment

This allows register and administer comprehensive risk assessment

Vaccine Data Capture

This allows investigators to capture data on vaccine administered and doses

Routine Follow-up

The platform allows periodic follow-up post vaccination for vaccine adverse events (AESI)

Interactive Charts

Interactive charts allows visualisation of data in interactive chart and graphs

Dure offers a comprehensive Active Vaccine Surveillance (AVSS) platform to countries which has been configured and adapted for COVID-19 Vaccine programs as per the WHO guidelines which would allow countries to capture, harmonise and analyse AESIs (Adverse events of special interest) including delayed AESI, serious AESIs, AESIs in specific populations, and AESIs occurring during mass COVID-19 vaccination program.
Comparing the incidence of the AESI, identified via AVSS, for COVID-19 vaccinated and unvaccinated individuals will enable to ascertain if there is a link (signal) between the AESI and the COVID-19 vaccine and if there is need for further specific studies to confirm such an association.

ABOUT DURE TECHNOLOGIES

Dure is a global leader in providing digital solutions in public health. In association with Who, Dure has been supporting multiple countries in their Vaccine Safety initiatives. Recently Dure supported India in one of the largest COVID-19 Vaccine Safety initiative that is currently being by more than 1 million facilities across the country.

Dure has its footprints in more than 40 countries and has implemented more than 100+ digital innovation projects for UN agencies like Ministry of Health, WHO, UNAIDS, UNICEF, UNOPS, to large donor in the area of Vaccine, COVID, HIV, TB and many other public domain. Dure has an established network of on-site resources and local country partnerships to support these digital initiatives on the ground

Dure has also been associated with WHO at a strategic level which also includes Long Term Agreement (LTA) from 2020-2024 with WHO for the provisioning of strategic leadership assistance, digital health technology and innovation assessment, incubation and scale up, development of strategies, policies and investment plans. Dure Technologies is a pioneer Organization, which focused on providing innovative Digital Health solutions for social impact.

Apart from having a strong technical expertise, Dure follows a strong implementation science and design thinking approach to ensure successful implementation of these digital platforms in the countries.

COVID-19 PANDEMIC CONTROL APPROACH
Dure’s multi-sectorial approach that includes various stakeholders such as a country health program involved in screening, diagnosis, treatment and contact investigation of COVID-19 cases; global policy makers involved in monitoring real-time situation rooms and devising strategy for pandemic control at a global level, and more importantly general citizens, patient communities and high-risks groups like diabetes, TB, HIV patients, etc.
All this requires a much deeper engagement with the health systems in terms of evolving knowledge and awareness around COVID-19, precautionary measures, access to health system, psychosocial messaging and global solidarity to fight COVID-19.
Dure’s iMonitor+ platform – which has been leveraged by different countries and global stakeholders for disease elimination, community engagement, SDG monitoring and various other strategic health initiatives – also provides a key opportunity to monitoring and controlling of COVID-19 pandemic and help establish multi-stakeholder engagement towards this common goal.
360 DEGREE APPROACH FOR COVID-19 MONITORING AND CONTROL
Dure’s iMonitor+ platform enables a 360 degree approach towards disease elimination and pandemic control by harmonising programmatic efforts onto one single platform and data ecosystem. The diagram depicts how different modules of the iMonitor+ platform can be used by different groups such as health practitioners, policy makers and citizen and patient communities. The highly configurable, scalable, sustainable and modular approach of the platform enables a unique ecosystems leveraging data from various sources and activities and providing real-time insights thus helping timely decision making, planning and effective information dissemination.
The open source platform can be easily plugged-in in country’s data ecosystem thus enabling quick adoption and integration of the platform and usage within the country.

INNOVATIVE PLUG & PLAY SMART SET-UP APPROACH
The innovative smart configuration and back-end admin set-up of the iMonitor+ platform allows creation and management of COVID-19 project templates based on various Global and National guidelines.
Countries can leverage from the global recommended templates and can also adapt the platform to their country-specific needs, using the innovative and comprehensive smart set-up.
The smart set-up also allows configuration and creation of different use cases and services. The innovative form builder, alert configuration module, module for configuring dashboard and visualisation allows countries to make changes on the go and thus matching up to the evolving scenarios in the context of COVID-19 pandemic.
CASE STUDIES
SAF-VAC India
The application has been developed for supporting the AEFI program in India and is an end-to-end solution which helps the frontline workers and medical officers in reporting and investigation of an adverse event as per the WHO guidelines.
The app has been developed in collaboration with WHO, AEFI Committee and Ministry of Health India, and has been successfully rolled out across all states and districts throughout the country for the last five years. It is currently hosted in the Government's National Data Centre.
The application was also showcased at the 2017 GVSI Meeting as part of innovative solutions supporting the immunisation program.
AEFI Bangladesh
Vaccine adverse events information management system (VAEIMS) has been integrated with the country's own DHIS2-based EPI tracker (EPI software) supporting the country's immunization program. The application was conceptualized and developed in close accordance with WHO country office & AEFI Expert Review Committee, with the objective to have a single integrated DHIS2-based HMIS for all national programs including immunization.
The application has been customised for supporting the local languages and program variables and is currently hosted in the country server. A detailed training has also been conducted for orientation to the National EPI managers, staff of health management information system (HMIS), Directorate General of Drug Administration (DGDA), WHO country office, AEFI Expert Review Committee and other district-level staff.
AEFI Package
A complete solution for supporting the AEFI program has been launched for WHO: the package covers reporting, investigation and causality assessment for adverse events. The integrated solution and apps can also work as standalone applications, giving flexibility to the end users to use either one of the apps.
The solution also includes a training platform which helps the countries to understand, adapt and follow WHO guidelines supporting the Immunization program.
The training package was launched at GVSI Meeting 2017 and is currently being extensively used by countries for enhancing the program.
VAEIMS Sri Lanka
The VAEIMS application was adapted locally replacing the traditional systems to ensure a structured data collection and analysis. An extensive training program for EPI officers, along with WHO country division and district medical officers, was conducted for an effective rollout.
It is currently hosted in the country server and is being rolled out across districts with a phased approach.
VAEIMS Africa Region
The AEFI reporting application has been implemented and integrated with country systems for Uganda and Malawi. An extensive training program for end users and National EPI officers and AEFI committee members was also conducted to ensure that the rollout would be effective.
Country DHIS2 experts were consulted for the application development and deployment, to ensure all the required processes and controls were followed. The applications are now hosted on country servers as well.
COWIN SAF-VAC India
In collaboration with the National AEFI teams, MOH and WHO country office, the SAFVAC application was integrated with the National COVID Immunization systems as a tool for data collection of adverse events, including reporting and investigation for minor and serious events across India.
The platform provides data capture complemented by visualization and analysis on a real time basis, and is based on DHIS2. The application also provides timely output for National MIS systems for investigation and interventions.
The application has been developed for supporting the AEFI program in India and it’s an end-to-end solution which helps the frontline workers and medical officers in reporting and investigation of an adverse event as per the WHO guidelines.
The app has been developed in collaboration with WHO, AEFI Committee and Ministry of Health India, and it has been successfully rolled out in the country across all states and districts for the last five years. It is currently hosted in the Government's National Data Centre.
The application was also showcased at the 2017 GVSI Meeting as an innovative solution supporting the immunisation program.
Platform Offerings
Dure's AVSS platform is ready to use a platform which can be adapted and deployed in the country in a short period of time. The platform can be provided as an independent solution or can be harmonized and integrated with the existing data ecosystems like DHIS2, HMIS or any other Vaccine Safety systems that might. The video shows an overview of the platform and actual implementation of the platform in multiple countries.
The platform provides a comprehensive smart configuration set-up which would allow countries to adapt the solution based on country specific needs. This also allows the countries to keep making changes as per the evolving needs and newer guidelines on the COVID vaccine program thus making it highly sustainable and scalable.

Reporting

  • Recording of Minor, Serious, Severe events

  • Alerts for Reminders for vaccine uptake

  • Decision systems for risk profiling

  • Follow up modules for interventions

Investigation & Anlaysis

  • Evidence based event assesment

  • Algorithm based data ouputs

  • Role based access for outcome sharing

  • Training Package for simulation

Dashboard

  • Real time data analysis

  • Access drug side-effect and adverse event data

  • Behavioral data patterns based on predictive modelling

  • Interactive Module to interact with participants

COUNTRY ONBOARDING PROCESS

Contact Us

Write to us to express interest Email @ contact@duretechnologies.com

Schedule Demo

We will help schedule a live demonstration of the platform and discuss country adaptation and harmonisation needs

Collaborate

A simple step by step onboarding process finalisation of Technical Assistance model

Implement

Comprehensive digital platform and implementation package made available to the countries

ABOUT DURE TECHNOLOGIES
ABOUT DURE TECHNOLOGIES
Dure is a global leader in providing digital solutions in public health. In association with Who, Dure has been supporting multiple countries in their Vaccine Safety initiatives. Recently Dure supported India in one of the largest COVID-19 Vaccine Safety initiative that is currently being by more than 1 million facilities across the country.
Dure has its footprints in more than 40 countries and has implemented more than 100+ digital innovation projects for UN agencies like Ministry of Health, WHO, UNAIDS, UNICEF, UNOPS, to large donor in the area of Vaccine, COVID, HIV, TB and many other public domain. Dure has an established network of on-site resources and local country partnerships to support these digital initiatives on the ground
Dure has also been associated with WHO at a strategic level which also includes Long Term Agreement (LTA) from 2020-2024 with WHO for the provisioning of strategic leadership assistance, digital health technology and innovation assessment, incubation and scale up, development of strategies, policies and investment plans. Dure Technologies is a pioneer Organization, which focused on providing innovative Digital Health solutions for social impact.
Apart from having a strong technical expertise, Dure follows a strong implementation science and design thinking approach to ensure successful implementation of these digital platforms in the countries.

Contact Us

GENÈVE

Rue de Lausanne 37, 1201 Geneve, Switzerland

MUMBAI

1101/1102, Centrum IT Park, Opp. TMC Office Wagle Estate,Thane west- 400602

DELHI

"EMPOWERERS", 2nd & 3rd Floor, Saira Tower, Gulmohar Commercial Complex, New Delhi -110049

UK

63 Bartholomew Street, Newbury, England, RG14 7BE